PTC Therapeutics Announces Topline Results from Vatiquinone MOVE-FA Registration-Directed Trial ...Middle East

PR Newswire - News
- Conference call and webcast to be held at 5:00 pm EDT - SOUTH PLAINFIELD, N.J., May 23, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today reported topline results from the MOVE-FA trial of vatiquinone in patients with Friedreich ataxia. The study did not meet its primary...

Hence then, the article about ptc therapeutics announces topline results from vatiquinone move fa registration directed trial was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( PTC Therapeutics Announces Topline Results from Vatiquinone MOVE-FA Registration-Directed Trial )

Apple Storegoogle play

Last updated :

Also on site :